Distinct tumorigenic potential of abl and raf in B cell neoplasia: abl activates the IL-6 signaling pathway

Immunity. 1996 Jul;5(1):81-9. doi: 10.1016/s1074-7613(00)80312-x.

Abstract

The development of murine plasma cell tumors induced by raf/myc containing retroviruses is facilitated by T cells and completely dependent on IL-6. To determine whether kinases with differing specificities reflect alternative biochemical pathways in B cell tumorigenesis, we have employed an abl/myc containing retrovirus to assess neoplastic development. In contrast with raf/myc, abl/myc disease is T cell and IL-6 independent. An examination of the IL-6 signal transduction pathway reveals that this pathway, as defined by activation of Stat3, is inducible by IL-6 in raf/myc tumors but constitutively activated in abl/myc tumors. These findings provide a mechanism for the derivation of cytokine-independent plasma cell tumors and suggest that both IL-6-dependent and independent tumors may arise in vivo depending on the particular mutational events incurred during tumorigenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Base Sequence
  • Genes, abl / immunology*
  • Interleukin-6 / genetics
  • Interleukin-6 / immunology*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred DBA
  • Mice, Nude
  • Molecular Sequence Data
  • Phenotype
  • Plasmacytoma / genetics*
  • Plasmacytoma / immunology
  • Retroviridae Infections / genetics*
  • Retroviridae Infections / immunology
  • Signal Transduction / genetics*
  • Signal Transduction / immunology*
  • Tumor Virus Infections / genetics*
  • Tumor Virus Infections / immunology

Substances

  • Interleukin-6